She’s literally the first among equals. At first glance, Elizabeth Carr appears to be an average, 44-year-old East Coaster. But unbeknownst to most, she’s made an indelible mark on US history as the ...

Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ...

Eligible patients can receive up to 70 per cent in subsidies for genetic tests, while MediShield Life coverage will be extended to selected risk-reducing surgical procedures.

An AI tool to help doctors flag Healthier SG enrollees at high risk of chronic disease will also be rolled out Read more at The Business Times.

Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today that it has ...

Abstract: In this paper, a new composite NDT testing sensor for boiler water wall tubes defect detection is designed which using a combination of the electromagnetic acoustic transducer (EMAT) method, ...

Fallopian tube cancer, a rare gynecologic cancer, is gaining awareness due to its potential origin for many high-grade serous ovarian cancers. New diagnostics improve early detection and treatment, ...

Abstract: The main aim of this study is to determine the effectiveness of a penetration testing tool, GyoiThon as a Machine Learning tool by conducting penetration tests on websites, including the ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code SK006, as the only ...

Evidence-based recommendations on niraparib (Zejula) for maintenance treatment of advanced (FIGO stages 3 and 4) ovarian, fallopian tube or peritoneal cancer after response to first-line ...

SANTA CLARA, Calif., February 12, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code ...